Issue 11/1997
Content (21 Articles)
Possible role of free radicals generated by pseudohypoxia in the regulation of hepatic glucose output. An in vitro model using rat liver microsomal glucose 6-phosphatase
I. Wittmann, I. Mazák, L. Wagner, J. Nagy
Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect of insulin treatment
Á Vér, I. Szántó, T. Bányász, P. Csermely, E. Végh, J. Somogyi
Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin
R. B. Fraser, G. Rowden, P. Colp, J. R. Wright
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia
A. Sainsbury, F. Rohner-Jeanrenaud, I. Cusin, K. E. Zakrzewska, P. A. Halban, R. C. Gaillard, B. Jeanrenaud
Effects of 4 weeks’ administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations
R. G. Thompson, L. Pearson, O. G. Kolterman
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
J. C. Pickup, M. B. Mattock, G. D. Chusney, D. Burt
Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM
A. Doria, T. Onuma, J. H. Warram, A. S. Krolewski
Evidence that insulin can directly inhibit hepatic glucose production
P. Maheux, Y. D. I. Chen, K. S. Polonsky, G. M. Reaven
Cardiac disease in diabetic end-stage renal disease
R. N. Foley, B. F. Culleton, P. S. Parfrey, J. D. Harriett, G. M. Kent, D. C. Murray, Paul E. Barre
New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland
J. Rissanen, J. Pihlajamäki, S. Heikkinen, P. Kekäläinen, L. Mykkänen, J. Kuusisto, A. Kolle, M. Laakso
Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia
E. Moberg, E. Hagström-Toft, P. Amer, J. Bolinder
Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM
E. C. I. Hatfield, C. J. Hawkes, M. A. Payton, M. R. Christie
Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study
J. J. J. de Sonnaville, M. Bouma, L. P. Colly, W. Devillé, D. Wijkel, R. J. Heine
Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study
E. J. Brunner, M. G. Marmot, K. Nanchahal, M. J. Shipley, S. A. Stansfeld, M. Juneja, K. G. M. M. Alberti
The JEVIN trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990
R. Schiel, U. A. Müller, H. Sprott, A. Schmelzer, B. Mertes, W. Hunger-Dathe, I. S. Ross
Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
M. Kellerer, M. Koch, E. Metzinger, J. Mushack, E. Capp, H. U. Häring
Preliminary data on a genome search in NIDDM siblings: the NIDDM 1 locus on chromosome 2 is not linked to NIDDM in the Sardinian population
M. Ciccarese, G. Tonolo, I. Delin, F. K. Wong, M. M. Atzeni, P. Lichtenstein, I. Kockum, M. Maioli, H. Luthman
Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations
A. T. Hattersley, P. M. Clark, R. Page, J. C. Levy, L. Cox, C. N. Hales, R. C. Turner